Alticor Corporate Enterprises
1
30M
1
0.02
1
- Areas of investment
Summary
The company was established in North America in United States. The main department of described Corporate Investor is located in the Ada.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Bay City Capital, New Enterprise Associates, Delta Dental.
Among the various public portfolio startups of the fund, we may underline Interleukin Genetics We can highlight the next thriving fund investment areas, such as Health Care, Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The higher amount of exits for fund were in 2003. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2006.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Biotechnology (1)
- Genetics (1)
- Medical (1)
- Health Care (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Avg. company exit year
- 20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.